摘要
The emergence of immunotherapy,particularly immune checkpoint inhibitors(ICIs),represents a groundbreaking approach to treating gastric cancer(GC).However,the prognosis of GC patients receiving ICI treatment is influenced by various factors.This manuscript identified sarcopenia and myosteatosis as independent prognostic factors impacting the outcomes of GC patients treated with ICIs.Additionally,this study introduced a visual predictive model to estimate the prognosis of GC patients.If confirmed by further studies,this observation could provide valuable insights to propel the advancement of personalized clinical medicine and the integration of precision medicine practices.
基金
Supported by National Nature Science Foundation of China,No.82320108022
Shanghai Rising-Star Program,No.21QA1409000
Shanghai Frontier Research Base of Disease and Syndrome Biology of Inflammatory Cancer Transformation,No.2021KJ03-12.
